rifampin	rosiglitazone	1	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  		9384	84108	9384	C089730
rifampin	rosiglitazone	1	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  		9384	84108	9384	C089730
rifampin	rosiglitazone	1	2	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.  		9384	84108	9384	C089730
rifampin	rosiglitazone	1	2	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.  		9384	84108	9384	C089730
rifampin	gemfibrozil	1	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  		9384	4719	9384	D015248
rifampin	gemfibrozil	1	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  		9384	4719	9384	D015248
rosiglitazone	gemfibrozil	1	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  		84108	4719	C089730	D015248
rosiglitazone	gemfibrozil	1	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  		84108	4719	C089730	D015248
rosiglitazone	gemfibrozil	2	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.  		84108	4719	C089730	D015248
rosiglitazone	gemfibrozil	2	1	false	none	7 DRUG INTERACTIONS    7.1 CYP2C8 Inhibitors and Inducers    An inhibitor of CYP2C8 (e.g., gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (e.g., rifampin) may decrease the AUC of rosiglitazone.  Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.  		84108	4719	C089730	D015248
